Adage Capital Partners Gp, L.L.C. Kodiak Sciences Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,139,527 shares of KOD stock, worth $5.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,139,527Holding current value
$5.4 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding KOD
# of Institutions
109Shares Held
40.9MCall Options Held
28.4KPut Options Held
21.2K-
Baker Bros. Advisors LP New York, NY17.3MShares$82.1 Million1.91% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$18.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.68MShares$7.97 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.53MShares$7.26 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$6.01 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $247M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...